Chemo Drug May Buy Time for Those With Bile Duct Cancer

THURSDAY, May 18, 2017 -- The chemotherapy drug Xeloda may prolong survival in those struck by a type of digestive system cancer, a new study finds. People with bile duct cancer who received the medication lived for an average of about 17 months...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news